Prevalence of mastocytosis and Hymenoptera venom allergy in the United States

• Published in: Journal of allergy and clinical immunology Vol. 148; no. 5; pp. 1316 - 1323
• Main Authors: Schuler, Charles F., Volertas, Sofija, Khokhar, Dilawar, Yuce, Huseyin, Chen, Lu, Baser, Onur, Montejo, Jenny M., Akin, Cem
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.2021
• Subjects: anaphylaxis; mast cell activation syndrome; mast cell disease; mastocytosis; Tryptase; venom allergy; venom immunotherapy; VIT; LOC; ACE; anaphylaxis; MCD; HVA; mastocytosis; Tryptase; venom allergy; SM; venom immunotherapy; mast cell disease; mast cell activation syndrome

Mastocytosis is a risk factor for Hymenoptera venom anaphylaxis (HVA). Current guidelines recommend measuring tryptase in patients with HVA and that those with mastocytosis pursue lifelong venom immunotherapy (VIT). Available data on HVA and mastocytosis largely derive from European single-center st...